Waters Key Executives
This section highlights Waters's key executives, including their titles and compensation details.
Find Contacts at Waters
(Showing 0 of )
Waters Earnings
This section highlights Waters's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-12 | $4.03 | $4.10 |
| Read Transcript | Q3 | 2024 | 2024-11-01 | $2.68 | $2.93 |
| Read Transcript | Q2 | 2024 | 2024-07-31 | $2.56 | $2.63 |
| Read Transcript | Q1 | 2024 | 2024-05-07 | $2.10 | $2.21 |
| Read Transcript | Q4 | 2023 | 2024-02-06 | $3.55 | $3.62 |
| Read Transcript | Q3 | 2023 | 2023-11-07 | $2.55 | $2.84 |
| Read Transcript | Q2 | 2023 | 2023-08-02 | $2.59 | $2.80 |
| Read Transcript | Q1 | 2023 | 2023-05-09 | $2.61 | $2.49 |
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
$368.53
Stock Price
$21.89B
Market Cap
7.60K
Employees
Milford, MA
Location
Financial Statements
Access annual & quarterly financial statements for Waters, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $2.96B | $2.96B | $2.97B | $2.79B | $2.37B |
| Cost of Revenue | $747.92M | $1.20B | $1.25B | $1.16B | $1.01B |
| Gross Profit | $2.21B | $1.76B | $1.72B | $1.63B | $1.36B |
| Gross Profit Ratio | 74.72% | 59.60% | 58.00% | 58.50% | 57.44% |
| Research and Development Expenses | $183.03M | $174.94M | $176.19M | $168.36M | $140.78M |
| General and Administrative Expenses | $- | $690.34M | $651.03M | $619.97M | $547.70M |
| Selling and Marketing Expenses | $- | $7.00M | $7.00M | $7.00M | $6.00M |
| Selling General and Administrative Expenses | $690.15M | $736.01M | $658.03M | $626.97M | $553.70M |
| Other Expenses | $510.94M | $32.56M | $6.37M | $7.14M | $10.59M |
| Operating Expenses | $1.38B | $943.52M | $840.58M | $802.47M | $705.06M |
| Cost and Expenses | $2.13B | $2.14B | $2.09B | $1.96B | $1.71B |
| Interest Income | $17.42M | $16.62M | $11.02M | $12.22M | $16.27M |
| Interest Expense | $89.68M | $98.86M | $37.78M | $32.72M | $32.80M |
| Depreciation and Amortization | $191.82M | $165.91M | $130.42M | $131.68M | $125.36M |
| EBITDA | $1.04B | $1.00B | $1.01B | $958.42M | $777.97M |
| EBITDA Ratio | 35.03% | 33.86% | 34.18% | 35.03% | 33.28% |
| Operating Income | $826.35M | $817.68M | $873.39M | $821.71M | $645.49M |
| Operating Income Ratio | 27.93% | 27.66% | 29.39% | 29.50% | 27.29% |
| Total Other Income Expenses Net | $-71.48M | $-81.43M | $-35.55M | $-15.51M | $-34.58M |
| Income Before Tax | $754.87M | $736.24M | $837.85M | $806.19M | $610.91M |
| Income Before Tax Ratio | 25.52% | 24.90% | 28.19% | 28.94% | 25.83% |
| Income Tax Expense | $117.03M | $94.01M | $130.09M | $113.35M | $89.34M |
| Net Income | $637.83M | $642.23M | $707.75M | $692.84M | $521.57M |
| Net Income Ratio | 21.56% | 21.72% | 23.81% | 24.87% | 22.05% |
| EPS | $10.75 | $10.87 | $11.80 | $11.25 | $8.40 |
| EPS Diluted | $10.71 | $10.84 | $11.73 | $11.17 | $8.36 |
| Weighted Average Shares Outstanding | 59.33M | 59.08M | 59.98M | 61.58M | 62.09M |
| Weighted Average Shares Outstanding Diluted | 59.55M | 59.27M | 60.33M | 62.03M | 62.41M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 28, 2024 | June 29, 2024 | March 30, 2024 | December 31, 2023 | September 30, 2023 | July 01, 2023 | April 01, 2023 | December 31, 2022 | October 01, 2022 | July 02, 2022 | April 02, 2022 | December 31, 2021 | October 02, 2021 | July 03, 2021 | April 03, 2021 | December 31, 2020 | September 26, 2020 | June 27, 2020 | March 28, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $872.71M | $740.30M | $708.53M | $636.84M | $819.47M | $711.69M | $740.58M | $684.67M | $858.51M | $708.55M | $714.32M | $690.57M | $836.45M | $659.23M | $681.65M | $608.54M | $786.66M | $593.78M | $519.98M | $464.94M |
| Cost of Revenue | $348.52M | $313.25M | $300.90M | $273.83M | $330.51M | $291.41M | $301.08M | $284.38M | $348.19M | $307.10M | $307.21M | $285.69M | $351.00M | $271.13M | $280.25M | $254.15M | $320.57M | $262.34M | $213.13M | $210.64M |
| Gross Profit | $524.20M | $427.06M | $407.63M | $363.01M | $488.97M | $420.29M | $439.50M | $400.29M | $510.32M | $401.45M | $407.11M | $404.89M | $485.44M | $388.11M | $401.39M | $354.40M | $466.09M | $331.44M | $306.85M | $254.29M |
| Gross Profit Ratio | 60.07% | 57.70% | 57.50% | 57.00% | 59.70% | 59.10% | 59.30% | 58.50% | 59.40% | 56.70% | 57.00% | 58.60% | 58.00% | 58.90% | 58.90% | 58.20% | 59.25% | 55.82% | 59.01% | 54.69% |
| Research and Development Expenses | $46.91M | $45.34M | $46.18M | $44.59M | $44.39M | $41.99M | $45.87M | $42.69M | $48.28M | $43.44M | $44.01M | $40.47M | $43.33M | $41.99M | $44.95M | $38.09M | $39.66M | $34.97M | $31.16M | $34.99M |
| General and Administrative Expenses | $- | $- | $- | $- | $171.67M | $- | $- | $- | $167.26M | $- | $- | $- | $166.01M | $- | $- | $- | $147.08M | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $7.00M | $- | $- | $- | $7.00M | $- | $- | $- | $7.00M | $- | $- | $- | $6.00M | $- | $- | $- |
| Selling General and Administrative Expenses | $173.27M | $172.10M | $170.25M | $174.54M | $178.67M | $186.75M | $186.95M | $181.96M | $174.26M | $164.42M | $161.88M | $157.47M | $173.01M | $152.54M | $158.21M | $143.20M | $153.08M | $135.43M | $117.45M | $147.74M |
| Other Expenses | $11.75M | $- | $-302.00K | $22.08M | $-557.00K | $328.00K | $-352.00K | $1.48M | $1.50M | $1.59M | $1.60M | $1.67M | $-870.00K | $-607.00K | $9.32M | $9.36M | $374.00K | $-1.04M | $-736.00K | $-374.00K |
| Operating Expenses | $231.94M | $217.43M | $216.43M | $219.13M | $223.06M | $240.86M | $239.64M | $226.13M | $224.04M | $209.44M | $207.48M | $199.62M | $218.08M | $196.29M | $204.97M | $183.13M | $195.43M | $173.06M | $151.22M | $185.35M |
| Cost and Expenses | $580.45M | $529.17M | $517.33M | $492.96M | $553.57M | $532.27M | $540.72M | $510.51M | $572.23M | $516.54M | $514.69M | $485.31M | $569.08M | $467.42M | $485.23M | $437.27M | $516.00M | $435.40M | $364.36M | $395.99M |
| Interest Income | $4.56M | $4.26M | $4.33M | $4.27M | $4.64M | $3.88M | $4.04M | $4.06M | $3.48M | $2.90M | $2.53M | $2.11M | $1.87M | $2.55M | $3.70M | $4.10M | $4.22M | $4.01M | $4.00M | $4.04M |
| Interest Expense | $19.00M | $21.43M | $23.73M | $25.52M | $26.07M | $26.56M | $23.27M | $10.38M | $10.41M | $9.52M | $8.89M | $8.95M | $9.01M | $8.53M | $8.33M | $6.84M | $6.83M | $6.91M | $9.02M | $10.04M |
| Depreciation and Amortization | $48.58M | $47.51M | $47.23M | $48.51M | $48.06M | $47.81M | $38.88M | $31.15M | $31.32M | $32.21M | $34.23M | $32.66M | $33.75M | $33.18M | $33.39M | $31.36M | $44.26M | $30.89M | $31.02M | $29.19M |
| EBITDA | $344.55M | $262.56M | $236.40M | $192.60M | $350.95M | $227.23M | $242.43M | $205.32M | $318.07M | $224.22M | $233.98M | $237.93M | $299.78M | $224.79M | $229.86M | $202.59M | $312.57M | $195.08M | $186.47M | $115.95M |
| EBITDA Ratio | 39.48% | 35.47% | 33.65% | 30.21% | 38.31% | 31.97% | 32.74% | 30.19% | 36.95% | 31.77% | 32.95% | 34.48% | 35.90% | 34.04% | 35.08% | 34.83% | 40.08% | 31.70% | 35.75% | 21.03% |
| Operating Income | $292.26M | $211.13M | $191.20M | $143.88M | $265.91M | $179.43M | $199.86M | $174.17M | $286.28M | $192.01M | $199.63M | $195.47M | $262.20M | $191.81M | $196.42M | $171.27M | $263.71M | $158.38M | $155.11M | $68.28M |
| Operating Income Ratio | 33.49% | 28.52% | 26.99% | 22.59% | 32.45% | 25.21% | 26.99% | 25.44% | 33.35% | 27.10% | 27.95% | 28.31% | 31.35% | 29.10% | 28.82% | 28.14% | 33.52% | 26.67% | 29.83% | 14.69% |
| Total Other Income Expenses Net | $-15.28M | $-17.52M | $-19.70M | $-18.99M | $-26.62M | $-26.23M | $-19.58M | $-8.99M | $-10.79M | $-8.63M | $-7.36M | $-8.78M | $-9.88M | $-9.14M | $992.00K | $2.51M | $-6.46M | $-7.95M | $-9.75M | $-10.42M |
| Income Before Tax | $276.98M | $193.62M | $169.41M | $114.86M | $237.60M | $153.19M | $180.28M | $165.17M | $275.50M | $183.38M | $192.27M | $186.69M | $252.32M | $182.68M | $197.41M | $173.78M | $257.25M | $150.44M | $145.36M | $57.86M |
| Income Before Tax Ratio | 31.74% | 26.15% | 23.91% | 18.04% | 28.99% | 21.53% | 24.34% | 24.12% | 32.09% | 25.88% | 26.92% | 27.03% | 30.17% | 27.71% | 28.96% | 28.56% | 32.70% | 25.34% | 27.96% | 12.45% |
| Income Tax Expense | $45.59M | $32.11M | $26.68M | $12.66M | $21.39M | $18.64M | $29.72M | $24.25M | $48.43M | $27.38M | $27.41M | $26.86M | $36.08M | $21.49M | $30.12M | $25.66M | $38.94M | $23.67M | $22.43M | $4.30M |
| Net Income | $231.40M | $161.50M | $142.74M | $102.20M | $216.21M | $134.55M | $150.55M | $140.92M | $227.06M | $156.00M | $164.86M | $159.83M | $216.24M | $161.19M | $167.29M | $148.13M | $218.31M | $126.77M | $122.93M | $53.56M |
| Net Income Ratio | 26.51% | 21.82% | 20.15% | 16.05% | 26.38% | 18.91% | 20.33% | 20.58% | 26.45% | 22.02% | 23.08% | 23.14% | 25.85% | 24.45% | 24.54% | 24.34% | 27.75% | 21.35% | 23.64% | 11.52% |
| EPS | $3.90 | $2.72 | $2.41 | $1.73 | $3.66 | $2.28 | $2.56 | $2.39 | $3.83 | $2.61 | $2.74 | $2.64 | $3.55 | $2.63 | $2.71 | $2.38 | $3.51 | $2.04 | $1.98 | $0.86 |
| EPS Diluted | $3.88 | $2.71 | $2.40 | $1.72 | $3.65 | $2.27 | $2.55 | $2.38 | $3.81 | $2.60 | $2.72 | $2.62 | $3.52 | $2.60 | $2.69 | $2.37 | $3.49 | $2.03 | $1.98 | $0.86 |
| Weighted Average Shares Outstanding | 59.39M | 59.31M | 59.34M | 59.23M | 59.14M | 59.09M | 58.86M | 59.02M | 59.33M | 59.80M | 60.21M | 60.58M | 60.98M | 61.36M | 61.69M | 62.26M | 62.17M | 62.00M | 61.94M | 62.23M |
| Weighted Average Shares Outstanding Diluted | 59.65M | 59.50M | 59.45M | 59.43M | 59.31M | 59.26M | 59.01M | 59.32M | 59.64M | 60.08M | 60.51M | 60.95M | 61.42M | 61.89M | 62.16M | 62.63M | 62.50M | 62.30M | 62.18M | 62.63M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $324.42M | $395.08M | $480.53M | $501.23M | $436.69M |
| Short Term Investments | $934.00K | $898.00K | $862.00K | $68.05M | $6.45M |
| Cash and Short Term Investments | $325.36M | $395.97M | $481.39M | $569.28M | $443.15M |
| Net Receivables | $733.37M | $702.17M | $722.89M | $612.65M | $573.32M |
| Inventory | $477.26M | $516.24M | $455.71M | $356.10M | $304.28M |
| Other Current Assets | $133.13M | $138.49M | $103.91M | $90.91M | $80.29M |
| Total Current Assets | $1.67B | $1.75B | $1.66B | $1.54B | $1.32B |
| Property Plant Equipment Net | $725.39M | $723.66M | $582.22M | $547.91M | $494.00M |
| Goodwill | $1.30B | $1.31B | $430.33M | $437.87M | $444.36M |
| Intangible Assets | $567.91M | $629.19M | $227.40M | $242.40M | $258.64M |
| Goodwill and Intangible Assets | $1.86B | $1.93B | $657.73M | $680.27M | $703.01M |
| Long Term Investments | $- | $4.83M | $19.16M | $- | $- |
| Tax Assets | $- | $- | $-19.16M | $- | $- |
| Other Non-Current Assets | $295.67M | $210.85M | $381.52M | $328.73M | $322.17M |
| Total Non-Current Assets | $2.88B | $2.87B | $1.62B | $1.56B | $1.52B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $4.55B | $4.63B | $3.28B | $3.09B | $2.84B |
| Account Payables | $99.93M | $84.70M | $93.30M | $96.80M | $72.21M |
| Short Term Debt | $25.54M | $105.65M | $102.86M | $55.81M | $205.53M |
| Tax Payables | $158.66M | $120.26M | $132.54M | $61.28M | $76.56M |
| Deferred Revenue | $250.81M | $256.68M | $227.91M | $227.56M | $198.24M |
| Other Current Liabilities | $254.82M | $222.29M | $229.12M | $239.06M | $252.44M |
| Total Current Liabilities | $789.76M | $789.58M | $785.74M | $680.51M | $804.98M |
| Long Term Debt | $1.68B | $2.36B | $1.59B | $1.57B | $1.27B |
| Deferred Revenue Non-Current | $- | $- | $57.00M | $46.00M | $42.00M |
| Deferred Tax Liabilities Non-Current | $- | $- | $-57.00M | $-46.00M | $-42.00M |
| Other Non-Current Liabilities | $258.73M | $322.49M | $404.24M | $473.38M | $528.08M |
| Total Non-Current Liabilities | $1.94B | $2.69B | $2.78B | $2.73B | $2.61B |
| Other Liabilities | $- | $- | $-785.74M | $-680.51M | $-804.98M |
| Total Liabilities | $2.73B | $3.48B | $2.78B | $2.73B | $2.61B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $1.63M | $1.63M | $1.62M | $1.62M | $1.62M |
| Retained Earnings | $9.79B | $9.15B | $8.51B | $7.80B | $7.11B |
| Accumulated Other Comprehensive Income Loss | $-155.28M | $-134.12M | $-141.57M | $-111.86M | $-117.94M |
| Other Total Stockholders Equity | $-7.81B | $-7.87B | $-7.86B | $-7.32B | $-6.76B |
| Total Stockholders Equity | $1.83B | $1.15B | $504.49M | $367.55M | $232.14M |
| Total Equity | $1.83B | $1.15B | $504.49M | $367.55M | $232.14M |
| Total Liabilities and Stockholders Equity | $4.55B | $4.63B | $3.28B | $3.09B | $2.84B |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $4.55B | $4.63B | $3.28B | $3.09B | $2.84B |
| Total Investments | $934.00K | $898.00K | $862.00K | $68.05M | $6.45M |
| Total Debt | $1.70B | $2.44B | $1.65B | $1.51B | $1.36B |
| Net Debt | $1.38B | $2.05B | $1.17B | $1.01B | $919.82M |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 28, 2024 | June 29, 2024 | March 30, 2024 | December 31, 2023 | September 30, 2023 | July 01, 2023 | April 01, 2023 | December 31, 2022 | October 01, 2022 | July 02, 2022 | April 02, 2022 | December 31, 2021 | October 02, 2021 | July 03, 2021 | April 03, 2021 | December 31, 2020 | September 26, 2020 | June 27, 2020 | March 28, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $324.42M | $330.51M | $326.43M | $337.29M | $395.08M | $336.41M | $329.69M | $486.07M | $480.53M | $443.64M | $418.90M | $480.07M | $501.23M | $524.70M | $460.06M | $683.78M | $436.69M | $374.93M | $339.04M | $390.06M |
| Short Term Investments | $934.00K | $944.00K | $934.00K | $923.00K | $898.00K | $898.00K | $885.00K | $885.00K | $862.00K | $876.00K | $897.00K | $23.02M | $68.05M | $130.49M | $203.57M | $125.99M | $6.45M | $22.14M | $16.72M | $3.81M |
| Cash and Short Term Investments | $325.36M | $331.46M | $327.36M | $338.21M | $395.97M | $337.31M | $330.58M | $486.95M | $481.39M | $444.51M | $419.79M | $503.10M | $569.28M | $655.19M | $663.62M | $809.77M | $443.15M | $397.07M | $355.76M | $393.87M |
| Net Receivables | $733.37M | $669.53M | $610.09M | $626.33M | $702.17M | $631.28M | $693.44M | $683.34M | $722.89M | $600.92M | $639.45M | $607.26M | $612.65M | $532.96M | $543.07M | $550.68M | $573.32M | $494.43M | $496.28M | $522.21M |
| Inventory | $477.26M | $518.99M | $522.93M | $538.63M | $516.24M | $544.40M | $536.83M | $499.42M | $455.71M | $442.24M | $409.92M | $381.90M | $356.10M | $388.76M | $348.77M | $327.97M | $304.28M | $326.95M | $344.01M | $344.01M |
| Other Current Assets | $133.13M | $127.74M | $143.31M | $139.78M | $138.49M | $121.53M | $120.34M | $103.98M | $103.91M | $87.91M | $95.16M | $92.92M | $90.91M | $81.17M | $83.09M | $79.51M | $80.29M | $73.22M | $73.39M | $67.69M |
| Total Current Assets | $1.67B | $1.65B | $1.60B | $1.64B | $1.75B | $1.51B | $1.68B | $1.67B | $1.66B | $1.49B | $1.47B | $1.49B | $1.54B | $1.58B | $1.56B | $1.69B | $1.32B | $1.22B | $1.20B | $1.26B |
| Property Plant Equipment Net | $651.20M | $719.27M | $717.23M | $714.66M | $723.66M | $616.85M | $707.62M | $590.21M | $582.22M | $547.39M | $545.81M | $547.20M | $547.91M | $530.06M | $527.13M | $513.72M | $494.00M | $469.72M | $459.17M | $439.42M |
| Goodwill | $1.30B | $1.31B | $1.30B | $1.30B | $1.31B | $1.31B | $1.31B | $431.64M | $430.33M | $420.26M | $428.00M | $435.81M | $437.87M | $436.75M | $439.83M | $438.14M | $444.36M | $431.08M | $427.49M | $423.79M |
| Intangible Assets | $567.91M | $591.88M | $596.40M | $611.15M | $629.19M | $631.21M | $649.73M | $232.72M | $227.40M | $213.43M | $225.10M | $236.41M | $242.40M | $246.08M | $246.84M | $240.85M | $258.64M | $255.17M | $248.99M | $243.39M |
| Goodwill and Intangible Assets | $1.86B | $1.90B | $1.89B | $1.91B | $1.93B | $1.94B | $1.96B | $664.36M | $657.73M | $633.69M | $653.11M | $672.22M | $680.27M | $682.83M | $686.66M | $678.99M | $703.01M | $686.25M | $676.49M | $667.18M |
| Long Term Investments | $- | $- | $6.01M | $7.64M | $4.83M | $129.00K | $53.00K | $121.00K | $19.16M | $278.00K | $31.17M | $8.16M | $- | $- | $- | $- | $- | $- | $4.39M | $10.01M |
| Tax Assets | $- | $- | $-1 | $- | $- | $-129.00K | $-53.00K | $-121.00K | $-19.16M | $-278.00K | $-31.17M | $-8.16M | $- | $- | $- | $- | $- | $- | $-4.39M | $-10.01M |
| Other Non-Current Assets | $- | $246.15M | $227.93M | $234.73M | $210.85M | $428.10M | $196.16M | $382.54M | $381.52M | $401.31M | $372.48M | $321.43M | $328.73M | $326.12M | $334.39M | $330.44M | $322.17M | $304.87M | $312.21M | $289.83M |
| Total Non-Current Assets | $2.51B | $2.86B | $2.85B | $2.87B | $2.87B | $2.98B | $2.87B | $1.64B | $1.62B | $1.58B | $1.57B | $1.55B | $1.56B | $1.54B | $1.55B | $1.52B | $1.52B | $1.46B | $1.45B | $1.41B |
| Other Assets | $369.86M | $1 | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $4.55B | $4.51B | $4.45B | $4.51B | $4.63B | $4.50B | $4.55B | $3.31B | $3.28B | $3.07B | $3.04B | $3.04B | $3.09B | $3.12B | $3.10B | $3.21B | $2.84B | $2.68B | $2.65B | $2.67B |
| Account Payables | $99.93M | $94.60M | $78.44M | $86.22M | $84.70M | $79.83M | $81.92M | $93.56M | $93.30M | $96.57M | $97.98M | $93.23M | $96.80M | $88.90M | $83.25M | $81.51M | $72.21M | $60.36M | $50.33M | $61.06M |
| Short Term Debt | $25.54M | $25.35M | $52.73M | $103.76M | $105.65M | $76.53M | $101.82M | $98.98M | $102.86M | $98.46M | $100.40M | $52.18M | $55.81M | $53.68M | $55.17M | $153.82M | $205.53M | $203.49M | $203.72M | $78.00M |
| Tax Payables | $158.66M | $150.24M | $134.26M | $120.52M | $120.26M | $112.68M | $121.29M | $150.69M | $132.54M | $116.82M | $104.98M | $82.63M | $61.28M | $61.40M | $52.58M | $82.64M | $76.56M | $60.44M | $87.84M | $46.88M |
| Deferred Revenue | $250.81M | $294.88M | $316.93M | $336.72M | $256.68M | $275.94M | $324.67M | $306.87M | $227.91M | $248.88M | $282.34M | $315.09M | $227.56M | $262.76M | $284.76M | $280.85M | $198.24M | $211.35M | $213.40M | $218.21M |
| Other Current Liabilities | $254.82M | $250.97M | $180.16M | $201.24M | $222.29M | $200.05M | $179.69M | $151.86M | $229.12M | $171.24M | $160.86M | $144.70M | $239.06M | $205.15M | $205.25M | $186.23M | $252.44M | $186.55M | $142.03M | $146.91M |
| Total Current Liabilities | $789.76M | $816.04M | $762.53M | $848.46M | $789.58M | $745.03M | $809.39M | $801.95M | $785.74M | $731.97M | $746.56M | $687.83M | $680.51M | $671.89M | $681.02M | $785.05M | $804.98M | $722.19M | $697.32M | $1.90B |
| Long Term Debt | $1.68B | $1.88B | $2.06B | $2.06B | $2.36B | $2.52B | $2.65B | $1.49B | $1.59B | $1.56B | $1.49B | $1.51B | $1.57B | $1.67B | $1.66B | $1.66B | $1.27B | $1.48B | $1.61B | $1.91B |
| Deferred Revenue Non-Current | $- | $63.00M | $66.00M | $70.00K | $67.00M | $64.00M | $69.00M | $66.00M | $57.00M | $55.00M | $60.00M | $53.00M | $46.00M | $44.00M | $47.00M | $47.00M | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $56.35M | $55.93M | $58.93M | $60.17M | $66.86M | $62.26M | $-57.00M | $-55.00M | $-60.00M | $-53.00M | $-46.00M | $-44.00M | $-47.00M | $-47.00M | $- | $- | $- | $- |
| Other Non-Current Liabilities | $258.73M | $150.00M | $212.19M | $342.29M | $322.49M | $331.19M | $320.53M | $412.66M | $404.24M | $396.75M | $406.93M | $473.25M | $473.38M | $476.81M | $489.58M | $530.96M | $528.08M | $514.87M | $532.74M | $543.87M |
| Total Non-Current Liabilities | $1.94B | $2.09B | $2.27B | $2.40B | $2.69B | $2.85B | $2.97B | $1.91B | $2.78B | $2.68B | $2.65B | $2.67B | $2.73B | $2.82B | $2.84B | $2.98B | $2.61B | $2.72B | $2.84B | $1.11B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $1 | $-785.74M | $-731.97M | $-746.56M | $-687.83M | $-680.51M | $-671.89M | $-681.02M | $-785.05M | $-804.98M | $-722.19M | $-697.32M | $- |
| Total Liabilities | $2.73B | $2.91B | $3.04B | $3.25B | $3.48B | $3.59B | $3.78B | $2.71B | $2.78B | $2.68B | $2.65B | $2.67B | $2.73B | $2.82B | $2.84B | $2.98B | $2.61B | $2.72B | $2.84B | $3.00B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $- | $1.63M | $1.63M | $1.63M | $1.63M | $1.63M | $1.63M | $1.63M | $1.62M | $1.62M | $1.62M | $1.62M | $1.62M | $1.62M | $1.62M | $1.62M | $1.62M | $1.61M | $1.61M | $1.61M |
| Retained Earnings | $- | $9.56B | $9.40B | $9.25B | $9.15B | $8.93B | $8.80B | $8.65B | $8.51B | $8.28B | $8.13B | $7.96B | $7.80B | $7.58B | $7.42B | $7.26B | $7.11B | $6.89B | $6.76B | $6.64B |
| Accumulated Other Comprehensive Income Loss | $- | $-132.28M | $-148.20M | $-141.88M | $-134.12M | $-146.30M | $-128.80M | $-132.80M | $-141.57M | $-164.39M | $-141.39M | $-117.72M | $-111.86M | $-115.61M | $-111.18M | $-111.21M | $-117.94M | $-126.68M | $-126.89M | $-138.42M |
| Other Total Stockholders Equity | $1.83B | $-7.82B | $-7.84B | $-7.86B | $-7.87B | $-7.88B | $-7.90B | $-7.92B | $-7.86B | $-7.73B | $-7.59B | $-7.47B | $-7.32B | $-7.18B | $-7.05B | $-6.92B | $-6.76B | $-6.81B | $-6.83B | $-6.84B |
| Total Stockholders Equity | $1.83B | $1.60B | $1.41B | $1.26B | $1.15B | $905.52M | $771.23M | $599.82M | $504.49M | $385.24M | $392.12M | $374.94M | $367.55M | $295.22M | $268.27M | $230.96M | $232.14M | $-41.58M | $-191.74M | $-338.00M |
| Total Equity | $1.83B | $1.60B | $1.41B | $1.26B | $1.15B | $905.52M | $771.23M | $599.82M | $504.49M | $385.24M | $392.12M | $374.94M | $367.55M | $295.22M | $268.27M | $230.96M | $232.14M | $-41.58M | $-191.74M | $-338.00M |
| Total Liabilities and Stockholders Equity | $4.55B | $4.51B | $4.45B | $4.51B | $4.63B | $4.50B | $4.55B | $3.31B | $3.28B | $3.07B | $3.04B | $3.04B | $3.09B | $3.12B | $3.10B | $3.21B | $2.84B | $2.68B | $2.65B | $2.67B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $4.55B | $4.51B | $4.45B | $4.51B | $4.63B | $4.50B | $4.55B | $3.31B | $3.28B | $3.07B | $3.04B | $3.04B | $3.09B | $3.12B | $3.10B | $3.21B | $2.84B | $2.68B | $2.65B | $2.67B |
| Total Investments | $934.00K | $944.00K | $6.94M | $8.56M | $5.73M | $1.03M | $938.00K | $1.01M | $862.00K | $876.00K | $897.00K | $23.02M | $68.05M | $130.49M | $203.57M | $125.99M | $6.45M | $22.14M | $16.72M | $3.81M |
| Total Debt | $1.70B | $1.90B | $2.09B | $2.14B | $2.44B | $2.59B | $2.72B | $1.57B | $1.65B | $1.62B | $1.56B | $1.47B | $1.54B | $1.64B | $1.63B | $1.83B | $1.53B | $1.75B | $1.87B | $3.81B |
| Net Debt | $1.38B | $1.57B | $1.76B | $1.80B | $2.05B | $2.26B | $2.39B | $1.08B | $1.17B | $1.18B | $1.14B | $990.14M | $1.04B | $1.12B | $1.17B | $1.15B | $1.10B | $1.37B | $1.53B | $3.42B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $637.83M | $642.23M | $707.75M | $692.84M | $521.57M |
| Depreciation and Amortization | $191.82M | $165.91M | $130.42M | $131.68M | $135.35M |
| Deferred Income Tax | $-877.00K | $-1.20M | $-31.99M | $16.63M | $-2.69M |
| Stock Based Compensation | $44.71M | $36.87M | $42.56M | $29.92M | $36.87M |
| Change in Working Capital | $-111.37M | $-240.26M | $-269.08M | $-107.17M | $96.72M |
| Accounts Receivables | $- | $49.18M | $-137.87M | $-62.45M | $37.47M |
| Inventory | $20.94M | $-45.44M | $-101.90M | $-67.25M | $18.94M |
| Accounts Payables | $- | $-79.52M | $60.98M | $46.11M | $140.60M |
| Other Working Capital | $-132.31M | $-164.47M | $-90.29M | $-23.58M | $-100.28M |
| Other Non Cash Items | $- | $-742.00K | $31.99M | $-16.63M | $2.69M |
| Net Cash Provided by Operating Activities | $762.12M | $602.81M | $611.66M | $747.27M | $790.51M |
| Investments in Property Plant and Equipment | $-142.48M | $-160.63M | $-183.46M | $-168.27M | $-172.38M |
| Acquisitions Net | $-1.49M | $-1.28B | $-1.37M | $7.00M | $-86.69M |
| Purchases of Investments | $-3.73M | $-1.79M | $-11.41M | $-63.36M | $-32.03M |
| Sales Maturities of Investments | $- | $2.51M | $86.90M | $218.08M | $20.86M |
| Other Investing Activities | $3.68M | $- | $1.37M | $-225.08M | $6.14M |
| Net Cash Used for Investing Activities | $-144.02M | $-1.44B | $-107.97M | $-231.63M | $-264.09M |
| Debt Repayment | $-730.00M | $780.00M | $60.00M | $160.00M | $-325.37M |
| Common Stock Issued | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-13.54M | $-70.28M | $-626.06M | $-648.93M | $-196.41M |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $46.87M | $45.23M | $56.43M | $50.66M | $81.27M |
| Net Cash Used Provided by Financing Activities | $-696.67M | $754.95M | $-509.63M | $-438.27M | $-440.50M |
| Effect of Forex Changes on Cash | $7.92M | $-948.00K | $-14.77M | $-12.83M | $15.07M |
| Net Change in Cash | $-70.66M | $-85.45M | $-20.70M | $64.54M | $100.98M |
| Cash at End of Period | $324.42M | $395.08M | $480.53M | $501.23M | $436.69M |
| Cash at Beginning of Period | $395.08M | $480.53M | $501.23M | $436.69M | $335.71M |
| Operating Cash Flow | $762.12M | $602.81M | $611.66M | $747.27M | $790.51M |
| Capital Expenditure | $-142.48M | $-160.63M | $-183.46M | $-168.27M | $-172.38M |
| Free Cash Flow | $619.64M | $442.18M | $428.20M | $579.01M | $618.12M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 28, 2024 | June 29, 2024 | March 30, 2024 | December 31, 2023 | September 30, 2023 | July 01, 2023 | April 01, 2023 | December 31, 2022 | October 01, 2022 | July 02, 2022 | April 02, 2022 | December 31, 2021 | October 02, 2021 | July 03, 2021 | April 03, 2021 | December 31, 2020 | September 26, 2020 | June 27, 2020 | March 28, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $231.40M | $161.50M | $142.74M | $102.20M | $216.21M | $134.55M | $150.55M | $140.92M | $227.06M | $156.00M | $164.86M | $159.83M | $216.24M | $161.19M | $167.29M | $148.13M | $218.31M | $126.77M | $122.93M | $53.56M |
| Depreciation and Amortization | $48.58M | $47.51M | $47.23M | $48.51M | $48.06M | $47.81M | $38.88M | $31.15M | $31.32M | $32.21M | $34.23M | $32.66M | $33.75M | $33.18M | $33.39M | $31.36M | $44.26M | $30.89M | $31.02M | $29.19M |
| Deferred Income Tax | $- | $-3.96M | $-495.00K | $4.45M | $-1.46M | $6.70M | $-1.36M | $-5.08M | $-11.15M | $-8.31M | $-16.70M | $4.17M | $7.41M | $3.11M | $3.32M | $2.79M | $-3.78M | $1.87M | $1.75M | $-2.52M |
| Stock Based Compensation | $11.72M | $10.65M | $11.43M | $10.91M | $4.64M | $8.49M | $10.93M | $12.80M | $11.63M | $10.21M | $9.79M | $10.93M | $7.97M | $6.35M | $7.29M | $8.30M | $9.15M | $9.59M | $8.93M | $9.20M |
| Change in Working Capital | $- | $49.58M | $-146.37M | $96.79M | $-37.23M | $-39.08M | $-180.89M | $16.95M | $-71.31M | $-40.33M | $-151.90M | $-5.47M | $-40.02M | $-32.83M | $-64.93M | $30.62M | $-4.24M | $5.33M | $35.94M | $59.69M |
| Accounts Receivables | $- | $-69.64M | $7.05M | $62.59M | $-51.15M | $50.05M | $6.23M | $44.05M | $-98.78M | $18.28M | $-56.47M | $-907.00K | $-85.92M | $4.49M | $11.04M | $7.95M | $-59.49M | $9.98M | $32.95M | $54.03M |
| Inventory | $- | $16.71M | $11.60M | $-28.31M | $35.97M | $-17.81M | $-20.99M | $-42.62M | $11.31M | $-48.14M | $-38.24M | $-26.83M | $26.63M | $-43.01M | $-20.33M | $-30.54M | $27.08M | $18.95M | $2.31M | $-29.40M |
| Accounts Payables | $- | $31.21M | $-12.79M | $-18.42M | $50.54M | $-7.23M | $-51.58M | $-71.26M | $65.94M | $27.25M | $37.35M | $-69.55M | $50.88M | $30.56M | $-5.57M | $-29.76M | $93.88M | $12.01M | $50.54M | $-15.82M |
| Other Working Capital | $- | $71.30M | $-152.23M | $80.93M | $-72.60M | $-64.10M | $-114.55M | $86.78M | $-49.77M | $-37.71M | $-94.55M | $91.82M | $-31.61M | $-24.87M | $-50.07M | $82.97M | $-65.71M | $-35.60M | $-49.86M | $50.89M |
| Other Non Cash Items | $-51.55M | $-60.70M | $100.03M | $92.08M | $65.31M | $-651.00K | $155.04M | $144.94M | $11.15M | $8.31M | $16.70M | $-4.17M | $-7.41M | $-3.11M | $-3.32M | $-2.79M | $3.78M | $-1.87M | $-1.75M | $2.52M |
| Net Cash Provided by Operating Activities | $240.14M | $204.58M | $54.53M | $262.87M | $230.12M | $157.82M | $18.12M | $196.75M | $198.71M | $158.09M | $56.98M | $197.96M | $217.94M | $167.89M | $143.04M | $218.40M | $267.48M | $172.58M | $198.81M | $151.63M |
| Investments in Property Plant and Equipment | $-52.10M | $-25.62M | $-36.10M | $-28.66M | $-41.59M | $-38.05M | $-46.61M | $-34.39M | $-62.18M | $-41.63M | $-39.27M | $-32.65M | $-44.65M | $-39.73M | $-44.39M | $-39.50M | $-47.04M | $-28.31M | $-45.90M | $-51.13M |
| Acquisitions Net | $- | $-425.00K | $- | $-1.06M | $3.55M | $651.00K | $-1.29B | $16.00K | $- | $-611.00K | $-20.60M | $- | $-921.00K | $-867.00K | $77.72M | $- | $-6.17M | $- | $- | $-76.66M |
| Purchases of Investments | $- | $-941.00K | $-932.00K | $-1.99M | $-91.00K | $-898.00K | $- | $-893.00K | $- | $-448.00K | $-1.74M | $-9.22M | $-921.00K | $-26.09M | $-92.50M | $-122.64M | $-5.72M | $-5.92M | $-16.26M | $-3.52M |
| Sales Maturities of Investments | $- | $933.00K | $921.00K | $898.00K | $91.00K | $1.54M | $- | $877.00K | $-8.90M | $3.70M | $22.34M | $51.64M | $62.37M | $99.36M | $14.78M | $3.14M | $19.11M | $215.00K | $397.00K | $1.14M |
| Other Investing Activities | $-9.00K | $- | $-11.00K | $-1.09M | $91.00K | $-651.00K | $- | $-16.00K | $8.90M | $611.00K | $20.60M | $9.22M | $921.00K | $72.40M | $-77.72M | $-119.50M | $2.29M | $-215.00K | $-397.00K | $-2.38M |
| Net Cash Used for Investing Activities | $-52.11M | $-26.05M | $-36.12M | $-29.74M | $-37.94M | $-37.40M | $-1.33B | $-34.41M | $-62.18M | $-38.38M | $-18.67M | $18.99M | $16.80M | $32.68M | $-122.10M | $-159.00M | $-37.53M | $-34.23M | $-62.16M | $-130.18M |
| Debt Repayment | $-200.00M | $-180.00M | $-50.00M | $-300.00M | $-150.00M | $-125.00M | $1.15B | $-94.96M | $30.00M | $60.00M | $40.00M | $-70.00M | $-100.00M | $5.10M | $-100.00M | $350.00M | $-215.00M | $-125.00M | $-200.00M | $214.63M |
| Common Stock Issued | $- | $3.24M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-66.00K | $-141.00K | $-245.00K | $-13.09M | $156.00K | $-692.00K | $-236.00K | $-69.50M | $-148.89M | $-155.22M | $-151.81M | $-170.14M | $-156.24M | $-151.19M | $-168.20M | $-173.31M | $-56.00K | $-56.00K | $-71.00K | $-196.23M |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $6.49M | $20.00K | $16.21M | $20.91M | $19.36M | $12.17M | $8.45M | $5.25M | $7.45M | $7.22M | $29.04M | $12.72M | $1.87M | $10.37M | $31.24M | $12.08M | $42.52M | $16.45M | $7.79M | $14.51M |
| Net Cash Used Provided by Financing Activities | $-193.58M | $-176.88M | $-34.04M | $-292.18M | $-130.49M | $-113.53M | $1.16B | $-159.21M | $-111.45M | $-88.01M | $-82.77M | $-227.41M | $-254.37M | $-135.72M | $-236.97M | $188.78M | $-172.53M | $-108.60M | $-192.28M | $32.92M |
| Effect of Forex Changes on Cash | $-541.00K | $2.44M | $4.75M | $1.26M | $-3.03M | $-171.00K | $-155.00K | $2.41M | $11.81M | $-6.96M | $-16.71M | $-10.71M | $-3.84M | $-208.00K | $-7.70M | $-1.09M | $4.35M | $6.15M | $4.61M | $-32.00K |
| Net Change in Cash | $-6.09M | $4.09M | $-10.86M | $-57.79M | $58.66M | $6.72M | $-156.38M | $5.54M | $36.89M | $24.74M | $-61.17M | $-21.16M | $-23.47M | $64.65M | $-223.73M | $247.09M | $61.76M | $35.90M | $-51.02M | $54.35M |
| Cash at End of Period | $324.42M | $330.51M | $326.43M | $337.29M | $395.08M | $336.41M | $329.69M | $486.07M | $480.53M | $443.64M | $418.90M | $480.07M | $501.23M | $524.70M | $460.06M | $683.78M | $436.69M | $374.93M | $339.04M | $390.06M |
| Cash at Beginning of Period | $330.51M | $326.43M | $337.29M | $395.08M | $336.41M | $329.69M | $486.07M | $480.53M | $443.64M | $418.90M | $480.07M | $501.23M | $524.70M | $460.06M | $683.78M | $436.69M | $374.93M | $339.04M | $390.06M | $335.71M |
| Operating Cash Flow | $240.14M | $204.58M | $54.53M | $262.87M | $230.12M | $157.82M | $18.12M | $196.75M | $198.71M | $158.09M | $56.98M | $197.96M | $217.94M | $167.89M | $143.04M | $218.40M | $267.48M | $172.58M | $198.81M | $151.63M |
| Capital Expenditure | $-52.10M | $-25.62M | $-36.10M | $-28.66M | $-41.59M | $-38.05M | $-46.61M | $-34.39M | $-62.18M | $-41.63M | $-39.27M | $-32.65M | $-44.65M | $-39.73M | $-44.39M | $-39.50M | $-47.04M | $-28.31M | $-45.90M | $-51.13M |
| Free Cash Flow | $188.03M | $178.96M | $18.43M | $234.22M | $188.53M | $119.77M | $-28.49M | $162.36M | $136.53M | $116.46M | $17.71M | $165.31M | $173.29M | $128.17M | $98.65M | $178.90M | $220.44M | $144.27M | $152.91M | $100.50M |
Waters Dividends
Explore Waters's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
-
Dividend Payout Ratio
-
Dividend Paid & Capex Coverage Ratio
5.35x
Waters Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.16 | $0.04 | November 26, 1996 |
Waters News
Read the latest news about Waters, including recent articles, headlines, and updates.
Winnebago Is Still Facing Choppy Waters
Winnebago Industries, Inc. is still trying to navigate a massive downturn in the RV and boating industry over the past couple of years. The company's earnings skyrocketed from $3.52/share in 2019 to $11.82/share in 2022, but have since plummeted since then. Winnebago is making smart moves to adjust to macroeconomic conditions, but it hasn't been enough to offset the huge decline in demand.
Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern
Waters Corp reported better-than-expected Q4'24 and FY'24 results, driven by strong performance in academia, government, and pharma segments, despite FX headwinds impacting gross margins. The company anticipates continued growth in 2025, with projected revenue growth between 4.5% and 7%, supported by emerging markets like India and high-growth areas like GLP-1 and PFAS testing. Risks include elevated valuations and limited opportunities for cash deployment, making buybacks less attractive; current valuation appears challenging compared to historical averages and peers.
Waters Corporation (WAT) Q4 2024 Earnings Call Transcript
Waters Corporation (NYSE:WAT ) Q4 2024 Earnings Conference Call February 12, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President & Chief Executive Officer Amol Chaubal - Senior Vice President & Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - Leerink Eve Burstein - Bernstein Brandon Couillard - Wells Fargo Dan Arias - Stifel Dan Brennan - TD Cowen Catherine Schulte - Baird Operator Good morning. Welcome to the Waters Corporation Fourth Quarter 2024 Financial Results Conference Call.
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results
Highlights Fourth Quarter 2024 Sales of $873 million exceeded high-end of guidance range, grew 6% as reported and 8% in constant currency Instruments grew 8% and recurring revenue grew 9% in constant currency, as growth accelerated across all three reported regions Pharma grew 10% in constant currency, reflecting stronger-than-expected year-end spending dynamics and broad-based growth across the Americas, Europe, and Asia GAAP EPS of $3.88; non-GAAP EPS of $4.10 grew 13% as strong operational performance and better-than-expected sales volume offset foreign exchange headwinds Full-Year 2024 Sales exceeded guidance at $2,958 million, flat as reported and in organic constant currency GAAP operating income margin of 27.9%; operational excellence drove adjusted operating income margin expansion to 31.0%, effectively neutralizing the challenges posed by foreign exchange headwinds GAAP EPS of $10.71; non-GAAP EPS of $11.86 grew 1% versus 2023, which includes a 5% impact due to foreign exchange headwinds Generated $762 million in operating cash flow; $744 million in free cash flow, representing 25% of full-year sales, and a free cash flow to adjusted net income ratio of 105% MILFORD, Mass. , Feb. 12, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced its financial results for the fourth quarter and full-year 2024.
Waters ElectroForce Apex 1 Instrument Offers Increased Versatility, Simplicity, and Speed to Mechanical Testing of Advanced Polymer Materials
News Summary: Offers increased versatility and data-driven insights with 43% greater motor stroke range (100 mm),1 expanding testing to more materials across diverse industries. Improved dynamic performance completes fatigue testing up to 30% faster than the competition,2 increasing the speed of product development and validation.
Weighing In On Waters Corporation: Facing A Valuation Headwind
Today, we take a more in-depth look at Waters Corporation, which provides analytical workflow solutions, primarily to the Pharma and Industrial industries. WAT stock has surged 35% since July lows, but analysts are growing increasingly cautious due to valuation concerns, with mixed ratings and tepid price targets. From a historical perspective, the equity now trades at the very top of its historical P/S and P/E ratios.
Innovative Waters TGA Smart-Seal Pans Enable Lower Cost, More Efficient Benchtop Analysis of Atmosphere-Sensitive Materials
News Summary: New and proprietary product enabling laboratories to analyze atmosphere-sensitive materials used to develop batteries, advanced polymers, and medicines in a standard laboratory benchtop-installed thermogravimetric analyzer (TGA). Reduces the cost and footprint of the TGA system by up to 50%i by helping eliminate the need for environment-controlled housing, or glovebox.
Waters Corporation Named to Dow Jones Sustainability Index for the Fourth Consecutive Year
MILFORD, Mass. , Dec. 23, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced it has been named to the Dow Jones Sustainability North America Index (DJSI North America) for the fourth consecutive year, based on the strength of its enterprise-wide sustainability practices.
Waters Highlights Continued Progress Towards Sustainability Commitments
News Summary: Exceeded its goal of reducing Scope 1 and 2 greenhouse gas emissions by 36% from a 2016 baseline, two years ahead of schedule. Invested in STEM education through the Waters Student Academy and Waters internship program, reaching hundreds of students with hands-on learning opportunities.
Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK
News summary: Newly built 45,000 sq ft facility houses engineering and skilled manufacturing employees at Longbridge Business Park, a specialized hub for science and technology. Waters triples manufacturing footprint while increasing precision machining and metrology capacity to support future growth.
Confluence's Revolution solution recognized as Best Buy-side Risk Management Initiative by Waters Technology
PITTSBURGH--(BUSINESS WIRE)--Confluence Technologies, Inc. (“Confluence”), a global technology solutions provider for regulatory, analytics, and investor communications solutions for the investment management industry, proudly announced that its Revolution solution for multi-asset performance, attribution and risk analytics, has been named Best Buy-side Risk Management Initiative in the Last 12 Months by Waters Technology's Buy-side Technology Awards, marking the fourth time Confluence has won.
Waters New Software Delivers Lab-Centric Business Intelligence and Enables Confident Audit-Readiness
News Summary: waters_connect™ Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation. Cloud-based software proactively provides visibility into risks that could trigger adverse regulatory findings, delivering seamless remote data access, comprehensive analytics, historical trends, scalability, and cost efficiency.
Artificial Intelligence Risk Inc. Named as Waters Technology's "Best buy-side AI platform or tool (compliance)" for the AIR- GPT Gen AI Platform
Waters Technology Recognizes Generative-AI Platform Focused on Compliance and Cybersecurity Greenwich, Connecticut--(Newsfile Corp. - November 4, 2024) - Artificial Intelligence Risk, Inc. (AI Risk, Inc.), the leader in Gen AI compliance and cybersecurity software, today announced its recognition as the best buy-side AI platform or tool (compliance) by WaterTechnology's 2024 Buy-Side Technology Awards. This acknowledgement, awarded as AI Risk, Inc. is growing rapidly in terms of both clients and staff, underscores the company's rapid and exceptional impact on the financial industry.
S&P 500 Gains and Losses Today: Waters Stock Surges as Sales Improve
Following a pair of negative trading sessions, major U.S. equities indexes closed out the week on a strong note, pushing higher on Friday as investors cheered upbeat earnings results from e-commerce and cloud computing behemoth Amazon (AMZN).
Waters Corporation (WAT) Q3 2024 Earnings Call Transcript
Waters Corporation (NYSE:WAT ) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Caspar Tudor – Head of Investor Relations Udit Batra – President and Chief Executive Officer Amol Chaubal – Senior Vice President and Chief Financial Officer Conference Call Participants Tycho Peterson – Jefferies Brandon Couillard – Wells Fargo Puneet Souda – Leerink Partners Vijay Kumar – Evercore ISI Dan Brennan – TD Cowen Matt Sykes – Goldman Sachs Operator Good morning, and welcome to the Waters Corporation Third Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode until the question-and-answer session begins.
Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results
Highlights Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currency Instruments returned to growth; recurring revenue grew high single-digits in constant currency All reported regions returned to growth in the quarter; sales grew across all end markets, led by Pharma & Industrial GAAP EPS of $2.71 and non-GAAP EPS of $2.93 significantly exceeded guidance, led by strong operational performance and better-than-expected market conditions Raised full-year sales and EPS guidance, with 5% to 7% constant currency growth expected in the fourth quarter Third Quarter 2024 MILFORD, Mass. , Nov. 1, 2024 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced its financial results for the third quarter of 2024.
Sailing In International Waters With LVHI
I avoid investing in non-democratic countries due to "Regime Risk," which can render traditional stock-picking rules irrelevant overnight. The MSCI World Index underperforms the S&P 500 in every category, suggesting that international equities may not be a wise investment. The Franklin International Low Volatility High Dividend Index ETF offers better risk management and dividend potential, making it a strong addition to my portfolio.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for WAT.